Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa (RTHS)

 

ID: NCT03040804

Sponsor: Montefiore Medical Center

Information provided by (Responsible Party):

Steven R Cohen, Montefiore Medical Center

 

Brief Summary:

To establish the safety of radiotherapy in the treatment of advanced hidradenitis suppurativa. Patients will receive radiotherapy treatment over one week and then they will be followed for the next three months.

 

https://clinicaltrials.gov/ct2/show/NCT03040804?cond=Hidradenitis+Suppurativa&cntry=US&draw=4&rank=21

 

Steven R Cohen, MD, MPH Montefiore Medical Center

Montefiore Medical Center Recruiting

Bronx, New York, United States, 10467

Contact: Steven R Cohen, MD, MPH  srcohen@montefiore.org   

Sub-Investigator: Nitin Ohri, MD         

Get Updates

Affiliated With

© 2020 by HS Connect   |  HSConnect.org@gmail.com  |  PO Box 73244 Puyallup, WA 98373  |  253.256.1579